BioSyent Inc. (RX.V) TSXV

12.80

+0.3(+2.40%)

Updated at December 24 12:59PM

Currency In CAD

Valuation

Market Cap127.45M
Enterprise Value116.38M
P/E Ratio16.69
PEG Ratio3.05
Price/Sales Ratio3.44
Price/Book Ratio3.61
Enterprise/Revenue3.06
Enterprise/EBITDA10.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.2
Operating Margin0.26

Management Effectiveness

Return On Assets0.18
Return On Equity0.23

Income Statement

Revenue35.03M
Revenue/Share3.75
Gross Profit27.86M
EBITDA10.43M
Net Income7.27M
Diluted EPS0.62

Balance Sheet

Total Cash23.4M
Total Cash/Share2.08
Total Debt892,878
Total Debt/Equity0.02
Current Ratio5.06
Book Value Per Share3.54

Price History

52-Week Change10.34
52-Week High12.8
52-Week Low9.2
Moving Average 50 Days11.39
Moving Average 200 Days11.41

Statistics

Average Volume3,977
Shares Outstanding11.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield1.56
Payout Ratio0.26
Last Split FactorN/A
Last Split DateN/A